Figure 2. HepCare Plus Model.

Table 1. Demographics of HepCare Plus Hepatitis C virus (HCV) RNA Positive Individuals.

Table 1. Demographics of HepCare Plus Hepatitis C virus (HCV) RNA Positive Individuals.

% (n) (N = 109)Gender   ⮚Male76% (n = 83)  ⮚Female24% (n = 26)Age, years (IQR)   ⮚Median age43 (39–48)Co-infection with HIV4.6% (n = 5)Aware of positive HCV status >1 year prior to screening *85.1% (80) *Referral Source   ⮚General Practices23.9% (n = 26)  ⮚Peer Facilitated22.9% (n = 25)  ⮚Hospital Referral (Inpatient/Outpatient)21.1% (n = 23)  ⮚Homeless Services20.2% (n = 22)  ⮚Addiction Services11.9% (n = 13)Treating Service at Mater Misericordiae University Hospital   ⮚Infectious Disease Clinic87.2% (n = 95)  ⮚Liver Centre12.8% (n = 14)

Table 2. Cascade of care results.

Table 2. Cascade of care results.

Number of Individuals (%)Of those who were assessed for treatment (n = 109)  ⮚Initiated treatment as of 3 November 2022100 (91.7%)  ⮚Due to commence treatment3 (2.8%)  ⮚Treatment deferred1 (0.9%)  ⮚Lost to follow up5 (4.6%)Of those who initiated treatment (n = 100)  ⮚Completed treatment with SVR * as of 3 November 202268 (68%)  ⮚Completed treatment with no follow up SVR30 (30%)  ⮚Defaulted treatment2 (2%)

Table 3. Comparison of Hepatitis C Virus (HCV) treatment figures.

Table 3. Comparison of Hepatitis C Virus (HCV) treatment figures.

YearHepCare PlusMMUH TotalNational Figures2022 *132213320214380554202024925672019 **2079344Total1002731598